MAPT and Alzheimer disease: By inhibiting PP2A, which dephosphorylates tau [21], OKA induces hyperphosphorylation of tau, leading to the formation of AD-driving toxic intracellular NFTs by detaching tau from microtubules and causing it to clump together.